Arthritis & Rheumatism · 2003 · 181 citations · 25 references
MedicineImmunologyInternal MedicineAutoimmunityImmunopathologyRheumatologyAutoantibodiesAutoimmune Disease PathogenesisAutoimmune DiseasesAutoimmune Rheumatic DiseasesSjogren SyndromeSjögren SyndromeAnti-ssa AntibodiesAnti-ssb AntibodiesClass Ii Hla AntibodiesHla AllelesHla Autoimmune Disease AssociationsHla Class Ii MoleculesHla Class Ii RestrictionPrimary Sjögren Syndrome
OBJECTIVE: To reevaluate, in a large series of patients with Sjögren's syndrome (SS) recruited from 2 French centers, the question of whether HLA is associated with SS itself or with a pattern of secretion of autoantibodies. METHODS: One hundred forty-nine white patients fulfilling the American-European Consensus Group criteria for SS were divided into 3 subgroups, according to their anti-Ro/SSA and anti-La/SSB status, as follows: group 1 (n = 53), no antibody; group 2 (n = 46), anti-SSA only; group 3 (n = 50), both anti-SSA and anti-SSB. Patients were compared with 222 unrelated healthy subjects representative of the white population in France. RESULTS: Comparisons between the 149 SS patients and 222 controls confirmed the association of SS with DRB1*03 (the frequency was 25% in patients versus 10% in controls) and DQB1*02 (32% versus 22%). The association between HLA and SS was restricted to patients with anti-SSA and/or anti-SSB; no association with HLA was observed in patients in group 1 (no antibody). The frequency of HLA-DRB1*15 was highest in group 2 (24%), compared with 11% in group 1 and 11% in controls, whereas the frequency of HLA-DRB1*03 was highest in group 3 (44%), compared with 12% in group 1, 19% in group 2, and 10% in controls. Group 2 and group 3 had more clinical and biologic markers of activity than did group 1 but were not clinically different. HLA alleles were not associated with clinical features of the disease, and were associated with only some biologic features: rheumatoid factor positivity, increased serum IgG, and thrombocytopenia were associated with HLA-DRB1*03, and neutropenia was associated with DQB1*01. CONCLUSION: HLA class II markers confer genetic susceptibility to Sjögren's syndrome. The association between HLA and SS is restricted to patients with anti-SSA and/or anti-SSB antibodies; HLA is not associated with SS in patients without these autoantibodies. The absence of a difference in disease severity between groups 2 and 3, as well as the restricted association of HLA-DRB1*03 in group 3, strongly suggest that HLA alleles predispose to autoantibody secretion, without being associated with clinical outcome. HLA class II phenotype might support epitope spreading: HLA-DR15 favors anti-SSA synthesis, whereas HLA-DR3 is associated with both anti-SSA and anti-SSB production.
25
Gene Interaction at HLA-DQ Enhances Autoantibody Production in Primary Sjögren's Syndrome
John B. Harley, Morris Reichlin, Frank C. Arnett et al. · Science · 1986 · 272 citations
Life Sciences, Genetics, Immunology +17
Richard Akin, A J Kreller, P J Walters · Plastic & Reconstructive Surgery · 1975 · 241 citations
Sjögren's Syndrome Associated with HLA-Dw3
Thomas M. Chused, Stuart S. Kassan, Gerhard Opelz et al. · New England Journal of Medicine · 1977 · 175 citations
Life Sciences, Genetics, Immunology +17
John D. Reveille, Mary Joan MacLeod, Karen B. Whittington et al. · The Journal of Immunology · 1991 · 159 citations
Life Sciences, Genetics, Immunology +17